Reference Guide for Management of Adult Immune Thrombocytopenia in Japan: 2019 Revision

Overview

Journal Int J Hematol

Specialty Hematology

Date 2020 Jan 4

PMID 31897887

Citations 21

Authors

Hirokazu Kashiwagi

Masataka Kuwana

Takaaki Hato

Toshiro Takafuta

Kingo Fujimura

Yoshiyuki Kurata

Mitsuru Murata

Yoshiaki Tomiyama

Affiliations

Soon will be listed here.

Citing Articles

Autoimmune Thrombocytopenia in Pregnancy: Insights from an Uncommon Case Presentation and Mini-Review.

Malutan A, Pascu O, Diculescu D, Ciortea R, Blaga L, Nicula R J Clin Med. 2025; 14(3).

PMID: 39941544 PMC: 11818785. DOI: 10.3390/jcm14030872.

Immune-Complex Mediated Mesangial Proliferative Glomerulonephritis with Full-House Pattern Observed During Treatment of Immune Thrombocytopenic Purpura.

Ueki A, Fukunaga T, Goto H, Minakuchi H, Oshima N Clin Med Insights Case Rep. 2024; 17:11795476241307123.

PMID: 39735784 PMC: 11672467. DOI: 10.1177/11795476241307123.

Successful rituximab treatment in a seronegative rheumatoid arthritis patient with concurrent cold agglutinin syndrome and immune thrombocytopenia.

Suzuki K, Akiyama M, Takei H, Kaneko Y Rheumatol Int. 2024; 45(1):2.

PMID: 39692788 DOI: 10.1007/s00296-024-05759-2.

Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan.

Kashiwagi H, Miura I, Terasawa N, Iwayama K, Furukawa Y, Kanenishi M Int J Hematol. 2024; 121(3):363-377.

PMID: 39668284 PMC: 11861122. DOI: 10.1007/s12185-024-03897-8.

Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study.

Mingot-Castellano M, Garcia-Donas G, Campos-Alvarez R, de Mora M, Luis-Navarro J, Dominguez-Rodriguez J J Clin Med. 2024; 13(21).

PMID: 39518433 PMC: 11547044. DOI: 10.3390/jcm13216294.

References

Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M . Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut. 2016; 65(9):1439-46. PMC: 5036253. DOI: 10.1136/gutjnl-2015-311304. View

Goodier C, Lu J, Hebbar L, Segal B, Goetzl L . Neuraxial Anesthesia in Parturients with Thrombocytopenia: A Multisite Retrospective Cohort Study. Anesth Analg. 2015; 121(4):988-991. DOI: 10.1213/ANE.0000000000000882. View

Boruchov D, Gururangan S, Driscoll M, Bussel J . Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood. 2007; 110(10):3526-31. DOI: 10.1182/blood-2007-01-065763. View

Cheng G, Saleh M, Marcher C, Vasey S, Mayer B, Aivado M . Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet. 2010; 377(9763):393-402. DOI: 10.1016/S0140-6736(10)60959-2. View

Asahi A, Kuwana M, Suzuki H, Hibi T, Kawakami Y, Ikeda Y . Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica. 2006; 91(10):1436-7. View

Chaturvedi S, Arnold D, McCrae K . Splenectomy for immune thrombocytopenia: down but not out. Blood. 2018; 131(11):1172-1182. PMC: 5855018. DOI: 10.1182/blood-2017-09-742353. View

Bussel J, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L . Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009; 373(9664):641-8. DOI: 10.1016/S0140-6736(09)60402-5. View

Zaja F, Vianelli N, Volpetti S, Battista M, Defina M, Palmieri S . Low-dose rituximab in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2010; 85(4):329-34. DOI: 10.1111/j.1600-0609.2010.01486.x. View

Auger S, Duny Y, Rossi J, Quittet P . Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis. Br J Haematol. 2012; 158(3):386-98. DOI: 10.1111/j.1365-2141.2012.09169.x. View

10.

Caulier M, Rose C, Roussel M, Huart C, Bauters F, Fenaux P . Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases. Br J Haematol. 1995; 91(2):477-9. DOI: 10.1111/j.1365-2141.1995.tb05326.x. View

11.

Hasan A, Michel M, Patel V, Stasi R, Cunningham-Rundles S, Leonard J . Repeated courses of rituximab in chronic ITP: Three different regimens. Am J Hematol. 2009; 84(10):661-5. PMC: 2783818. DOI: 10.1002/ajh.21512. View

12.

Porcelijn L, Huiskes E, Schipperus M, van der Holt B, de Haas M, Zwaginga J . Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients. Blood. 2017; 129(25):3389-3391. DOI: 10.1182/blood-2016-11-751719. View

13.

Lakhwani S, Perera M, Fernandez-Fuertes F, Rios de Paz M, Torres M, Raya J . Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres. Eur J Haematol. 2017; 99(4):372-377. DOI: 10.1111/ejh.12932. View

14.

Chugh S, Darvish-Kazem S, Lim W, Crowther M, Ghanima W, Wang G . Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet Haematol. 2015; 2(2):e75-81. DOI: 10.1016/S2352-3026(15)00003-4. View

15.

Gonzalez-Porras J, Escalante F, Pardal E, Sierra M, Garcia-Frade L, Redondo S . Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia. Eur J Haematol. 2013; 91(3):236-241. DOI: 10.1111/ejh.12146. View

16.

Neunert C, Noroozi N, Norman G, Buchanan G, Goy J, Nazi I . Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2014; 13(3):457-64. PMC: 4991942. DOI: 10.1111/jth.12813. View

17.

Nishimoto T, Numajiri M, Nakazaki H, Okazaki Y, Kuwana M . Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia. Int J Hematol. 2014; 100(4):341-4. DOI: 10.1007/s12185-014-1661-4. View

18.

Andersen J . Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med. 1994; 330(22):1560-4. DOI: 10.1056/NEJM199406023302203. View

19.

Wang L, Gao Z, Chen X, Zhang H, Yang N, Wang F . Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis. Sci Rep. 2016; 6:39003. PMC: 5171907. DOI: 10.1038/srep39003. View

20.

Audia S, Godeau B, Bonnotte B . Is there still a place for "old therapies" in the management of immune thrombocytopenia?. Rev Med Interne. 2015; 37(1):43-9. DOI: 10.1016/j.revmed.2015.08.007. View